BGI and ACRG announce cancer collaboration

BGI and Asia Cancer Research Group (ACRG) have announced they are to collaborate on cancer research.

The two organizations will work together to conduct genomic research on lung cancer and liver cancer, which are two of the most common cancers in Asia. ACRG will provide samples of lung and liver cancer tissues, and BGI will sequence the samples on its large-scale next-generation sequencing platforms and provide bioinformatics analysis. The resulting data source will be freely shared with the scientific community.

Dr Mao Mao, President of ACRG, said, “The collaboration will accelerate the establishment of a pharmacogenic database for Asian lung and liver cancers. We are hoping to increase our knowledge of these two common cancers in Asia, and to accelerate the development of new diagnostic methods and therapies.”

Professor Huanming Yang, Chairman of BGI, commented, “We are very excited about this new partnership with ACRG. Given BGI’s expertise in genomics research and ACRG’s advances in cancer studies, I believe this partnership will accelerate cancer research and bring new perspectives for researchers that could facilitate biotechnology and pharmaceutical research in the future.”

For more information please visit

ref="http://www.genomics.cn">www.genomics.cn